Treatment of Crohn’s disease-related high perianal fistulas combining the mucosa advancement flap with platelet-rich plasma: a pilot study - Takeaways - MDSpire

Treatment of Crohn’s disease-related high perianal fistulas combining the mucosa advancement flap with platelet-rich plasma: a pilot study

  • By

  • K. W. A. Göttgens

  • R. R. Smeets

  • L. P. S. Stassen

  • G. L. Beets

  • M. Pierik

  • S. O. Breukink

  • May 15, 2015

  • 0 min

Share

  • 1

    High perianal fistulas (HPFs) are challenging to treat, with no consensus on the best technique for management.

  • 2

    The study evaluated a novel technique combining mucosa advancement flap (MAF) with platelet-rich plasma (PRP) for Crohn’s disease-related fistulas.

  • 3

    In a pilot study, 80% of patients with Crohn’s disease-related high perianal fistulas achieved healing after treatment with MAF and PRP.

  • 4

    The median healing time for the treated fistulas was 52.5 days, with one patient experiencing delayed healing.

  • 5

    This study suggests that combining MAF with PRP may improve healing outcomes for complex Crohn’s disease-related fistulas.

Original Source(s)

Treatment of Crohn’s disease-related high perianal fistulas combining the mucosa advancement flap with platelet-rich plasma: a pilot study

  • by K. W. A. Göttgens, R. R. Smeets, L. P. S. Stassen, G. L. Beets, M. Pierik, S. O. Breukink

  • May 15, 2015

Related Content

A systematic review of classification systems for pilonidal sinus

Prophylactic negative-pressure wound therapy after ileostomy reversal for the prevention of wound healing complications in colorectal cancer patients: a randomized controlled trial

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.